期刊文献+

血液内科与呼吸内科特殊使用类抗菌药物182例应用分析 被引量:4

下载PDF
导出
摘要 目的了解我院血液内科、呼吸内科住院患者特殊使用类抗菌药物使用现状。方法收集本院血液内科、呼吸内科2011年1~3月特殊使用类抗菌药物申请表及出院病历182例,分析总结特殊使用类抗菌药物品种、感染疾病种类、病原学依据等。统计特殊使用类抗菌药物临床应用情况。结果血液内科、呼吸内科特殊使用类抗菌药物的应用较广泛,几乎涵盖了所有品种,其中以碳青酶烯类药物及糖肽类使用率较高。结论实施抗菌药物分级管理,是加强临床用药监控、减少细菌耐药性的有效手段。
出处 《西南国防医药》 CAS 2011年第10期1104-1105,共2页 Medical Journal of National Defending Forces in Southwest China
  • 相关文献

参考文献2

二级参考文献27

  • 1任南,吴安华,冯丽,文细毛,易霞云,吕一欣,龚瑞娥,黄勋,王曼平.住院患者抗菌药物临床应用横断面调查[J].中华医院感染学杂志,2006,16(9):1048-1050. 被引量:209
  • 2Hayden MK. Insights into the epidemiology and control of infection with vancom ycin resistant enterococci[J]. Clin Infect Dis,2001,31(4):1058-1065
  • 3Shinabarger DL, Marotti KR,Murray RW,et al.Mechanism of action of oxazolidinone s:effects of linezolid and eperezolid on translation reactions[J]. Antimicrob Agents Chemother,1997,41(10): 2132-2136
  • 4Kaatz GW,Seo SM. In vitro activities of oxazolidinone compounds U-100592 and U -100766 against Staphylococcus aureus and Staphylococcus epdermidis[J]. Antim icrob Agents Chemother, 1996,40(3):799-801
  • 5Zurenko GE,Yagi BH,Schaadt RD,et al.In vitro activities of U-100592 and U-1007 66,novel oxazolidinone antibacterial agents[J]. Antimicrob Agents Chemother,19 96,40(4):839-845
  • 6Jones RN,Johnson DM,Erwin ME.In vitro antimicrobial activities and spectra of U-100592 and U-100766,two novel fluorinated oxazolidinones[J]. Antimicrob Agents Chemother, 1996,40(3):720-726
  • 7Rybak MJ,Cappelletty DM,Moldovan T,et al.Comparative in vitro activities and p ostantibiotic effects of the oxazolidinone compounds eperezolid(PNU-100592) and linezolid(PNU-100766) versus vancomycin against Staphylococcus aureus,coagulas e-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium[J ]. Antimicrob Agents Chemother,1998,42(3):721-724
  • 8Diekema DI,Jones RN. Oxazolidinones[J]. Drugs,2000,59(1):7-16
  • 9Cercenado E,Garcia-Garrote F,Bouza E.In vitro activity of linezolid against mu ltiply resistant Gram-positive clinical isolates[J]. J Antimicrob Chemother, 2001,47(1):77-81
  • 10Moellering RC Jr. A novel antimicrobial agent joins the battle against resistant bacteria[J]. Ann Intern Med, 1999,130(2):155-157

共引文献25

同被引文献46

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部